Literature DB >> 24874430

Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori.

Po-Xing Zheng1, Hsin-Yi Fang2, Hsiao-Bai Yang3, Nai-Yueh Tien2, Ming-Cheng Wang4, Jiunn-Jong Wu5.   

Abstract

BACKGROUND/
PURPOSE: Helicobacter pylori is a human gastric pathogen. Antibiotic resistance of H. pylori has become a problem increasing the failure of H. pylori eradication. Therefore alternative approaches are required. The aim of this study was to evaluate the anti-H. pylori activity of Lactobacillus pentosus strain LPS16 and the mechanism of its killing effect.
METHODS: The anti-H. pylori activity of LPS16 was determined by the disc diffusion test and time killing assay. High-performance liquid chromatography analysis was used to analyze the secreted compounds of LPS16. Sixty H. pylori strains isolated from different gastric diseases, having different antibiotic susceptibility were collected to analyze the spectrum of anti-H. pylori activity of LPS16. Adhesion ability of LPS16 to gastric epithelial cell lines was assayed by flow cytometry.
RESULTS: The anti-H. pylori activity of LPS16 depended on the secreted component, and lactic acid mediated bactericidal activity against H. pylori. The bactericidal activity did not vary significantly among the strains isolated from different diseases having different antibiotic susceptibility. Moreover, LPS16 can adhere on gastric epithelial cell lines AKG and MKN45.
CONCLUSION: L. pentosus strain LPS16 had the broad-spectrum anti-H. pylori activity, suggesting that it can be used to prevent H. pylori infection.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Acid; Bactericidal; Helicobacter; Lactobacillus

Mesh:

Substances:

Year:  2014        PMID: 24874430     DOI: 10.1016/j.jmii.2014.04.014

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

Review 1.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

2.  Lactobacilli Reduce Helicobacter pylori Attachment to Host Gastric Epithelial Cells by Inhibiting Adhesion Gene Expression.

Authors:  Nele de Klerk; Lisa Maudsdotter; Hanna Gebreegziabher; Sunil D Saroj; Beatrice Eriksson; Olaspers Sara Eriksson; Stefan Roos; Sara Lindén; Hong Sjölinder; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

Review 3.  A Novel View of Human Helicobacter pylori Infections: Interplay between Microbiota and Beta-Defensins.

Authors:  Raffaela Pero; Mariarita Brancaccio; Sonia Laneri; Margherita-Gabriella De Biasi; Barbara Lombardo; Olga Scudiero
Journal:  Biomolecules       Date:  2019-06-18

4.  Lactobacillus gasseri Suppresses the Production of Proinflammatory Cytokines in Helicobacter pylori-Infected Macrophages by Inhibiting the Expression of ADAM17.

Authors:  Hanna G Gebremariam; Khaleda Rahman Qazi; Tanvi Somiah; Sushil Kumar Pathak; Hong Sjölinder; Eva Sverremark Ekström; Ann-Beth Jonsson
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 5.  Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.

Authors:  Jianfu Ji; Hong Yang
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.